Analysts at Credit Suisse downgraded Esperion Therapeutics, Inc. (ESPR) from ‘Neutral’ to ‘Underperform’ in a research report issued to clients …
View the full post at: Notable Analyst Calls: Esperion Therapeutics (ESPR), Zebra Technologies (ZBRA), Tesaro, Inc. (TSRO), Nike (NKE)